Pricing Log in Create free account

CASI Pharmaceuticals Inc. (CASIF) vs Tvardi Therapeutics, Inc. (TVRD)

CASI Pharmaceuticals Inc. and Tvardi Therapeutics, Inc. are both Biotechnology companies. CASI Pharmaceuticals Inc. and Tvardi Therapeutics, Inc. are of similar size ($12.4M and $11.5M). CASI Pharmaceuticals Inc. grew revenue faster over the last twelve months: −27.4% against −55.3%. Tvardi Therapeutics, Inc. has the higher net margin (0.00% vs −232.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, CASI Pharmaceuticals Inc. leads on 8 and Tvardi Therapeutics, Inc. on 8.

Valuation

Metric CASIF TVRD Biotechnology median
P/E n/m n/m 10.60
P/S 0.10 1.20 9.40
P/B n/m 1.09 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.80 6.98 9.02
Earnings yield (2,455.91%) (287.63%) (32.88%)
Free cash flow yield (3,455.46%) (309.54%) (23.13%)

Profitability

Metric CASIF TVRD Biotechnology median
Gross margin 48.65% 146.85% 68.51%
Operating margin (206.87%) 0.00% 0.00%
Net margin (232.03%) 0.00% 0.00%
Free cash flow margin (340.20%) 0.00% 0.00%
Return on equity 0.00% (126.19%) (51.96%)
Return on assets 0.00% (85.08%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CASIF TVRD Biotechnology median
Revenue growth (TTM) (27.42%) (55.30%) 6.76%
EPS growth (last fiscal year) (1.17%) 71.45% 29.88%
Revenue growth, 5-year CAGR 6.47% (18.53%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CASIF TVRD Biotechnology median
Debt to equity (0.34) 0.00 0.00
Current ratio 0.15 1.87 4.97
Net debt to EBITDA (0.43) 1.15 1.01

Dividend

Metric CASIF TVRD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CASIF TVRD Biotechnology median
Market cap 12.39m 11.53m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack